Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate pre-filled pen versus pre-filled syringe preference study in active rheumatoid arthritis
2012-000222-21Phase 2Completed
- Sponsor
- medac GmbH
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of methotrexate in rheumatoid arthritis (RA) (2 arms), sponsored by medac GmbH. Started Mar 2012; status: completed.
02
Drugs
methotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2012-000222-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000222-21.